University of Illinois Cancer Center
1801 West Taylor, Suite 1E
Chicago, Illinois 60612
312.355.1625 http://www.chicago.medicine.uic.edu/cancercenter

Use our guide to learn which trials are right for you!

The University of Illinois Cancer Center is dedicated to reducing the burden of cancer on the people of Illinois and beyond, through an integrated program of excellence in research, education, and outreach on the causes, prevention, detection and treatment of cancer.

As part of the University of Illinois College of Medicine, our four campuses in Chicago , Peoria, Rockford and Urbana function as one Cancer Center. We work collaboratively with the University of Illinois Schools of Nursing, Pharmacy, Dentistry, Allied Health Sciences, Public Health, and Veterinary Science, in the context of cancer biology, genetics, therapies, imaging, prevention and early detection, and psychosocial oncology. Finally, all of our campuses are integrated with the University of Illinois Hospital and Health Sciences System, where our facilities provide state-of-the-art treatment and serve as a model for clinical trials.

Research in the University of Illinois Cancer Center is organized into four broad thematic programs that are mechanism-based and focused on making discoveries that can lead to improvements in cancer treatment, diagmosis and prevention. They are tightly linked to clinical research and treatment working groups in areas such as breast cancer, lung cancer, gastro-intestinal cancers and prostate cancer. Our Cancer Center includes over 250 researchers and physicians, with a total of cancer-related research funding exceeding $59million.

The combination of our laboratory research, clinical trials and patient care, therefore enable our Cancer Center teams to actively translate knowledge gained, into improved quality of life for persons and families impacted by cancer.

We've found
17 trials
at this facility
Oncology Clinical Trial
Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Triple Negative Breast Cancer (TNBC) Clinical Trial
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)
Status: Enrolling, Phase III
Updated: 4/26/2018
mi
from
Chicago, IL
Click here to add this to my saved trials
Advanced Renal Cell Carcinoma Clinical Trial
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Lymphoma, T-Cell, Peripheral Clinical Trial
Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematologic Malignancies Clinical Trial
Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation
Status: Enrolling, Phase II
Updated: 11/13/2013
mi
from
Chicago, IL
Click here to add this to my saved trials
Dental / Maxillofacial Surgery Clinical Trial
DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
A Research Study for Latina Women After Breast Cancer Treatment
Status: Enrolling
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer
Status: Enrolling
Updated: 2/18/2011
mi
from
Chicago, IL
Click here to add this to my saved trials
Neurology, Oncology, Psychiatry / Psychology Clinical Trial
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 11/9/2012
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Non-Small-Cell Lung Cancer Clinical Trial
Phase II Trial of Continuation Therapy in Advanced NSCLC
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Stage IV Melanoma Clinical Trial
Abraxane Plus Bevacizumab Versus Ipilimumab as 1st Line Therapy for BRAFwt Metastatic Melanoma
Status: Enrolling, Phase II
Updated: 5/21/2014
mi
from
Chicago, IL
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Lycopene in Preventing Prostate Cancer in Healthy Participants
Status: Enrolling
Updated: 9/19/2013
mi
from
Chicago, IL
Click here to add this to my saved trials
Cancer Clinical Trial
Collecting Tumor Samples From Patients With Gynecological Tumors
Status: Enrolling
Updated: 8/30/2012
mi
from
Chicago, IL
Click here to add this to my saved trials
Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trial
Codex: Study of Inodiftagene Vixteplasmid (BC-819) in Unresponsive NMIBC
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials